Blog Archives

Le chronotype: la génétique derrière lève-tôt ou couche-tard

01 février 2019 – Lève-tôt ou couche-tard une question génétique? Ca c’est la question.

Vous préférez-vous lever tôt le matin ou vous endormir tard le soir ? La réponse est certainement déterminée par de nombreux facteurs, tels que le sexe, l’âge, mais aussi les habitudes et le mode de vie.

Read more ›

Tags : , , , , , , , , , , , ,

thasso: conditions

thasso: nouveaux tweets

thasso: commentaires récents

View my Flipboard Magazine.

thasso: catégories

thasso: archives

thasso: chat simple

Vous devez être un utilisateur inscrit pour participer à ce tchat.

  • Diagnostic, therapeutic advance for rare neurodegenerative disorder octobre 21, 2020
    Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3)—a disease that has no cure. They also have clarified the role of a gene target associated with the disease.
  • Scientists identify compound that stimulates muscle cells in mice octobre 21, 2020
    UCLA researchers have identified a compound that can reproduce the effect of exercise in muscle cells in mice. The findings are published in the journal Cell Reports Medicine.
  • Genome archeologists discover path to activate immune response against cancer octobre 21, 2020
    Ancient embedded elements in our DNA from generations past can activate a powerful immune response to kill cancer cells like an infection.
  • Genomic differences may be key to overcoming prostate cancer disparities octobre 21, 2020
    Prostate cancer is the most common type of cancer among American men after skin cancer, but the disease does not affect all races equally. African American men are nearly two times more likely to develop prostate cancer, and more often have an aggressive form of the disease that grows and spreads quickly. They are also […]
  • Epigenomic platform detects early-stage pancreatic cancer octobre 21, 2020
    Bluestar Genomics has published study results in the peer-reviewed journal Nature Communications demonstrating the power of the company's platform to detect pancreatic cancer in its early stages, addressing the unmet need of more than 60,000 patients diagnosed with the disease each year in the United States alone. The epigenomic platform analyzes a simple blood draw […]
  • Virtual Reality health appointments can help patients address eating disorders octobre 21, 2020
    Research from the University of Kent, the Research centre on Interactive Media, Smart systems and Emerging technologies -- RISE Ltd and the University of Cyprus has revealed that Virtual Reality (VR) technology can have significant impact on the validity of remote health appointments for those with eating disorders, through a process called Virtual Reality Exposure […]
  • The soft power concept of German energy foreign policy octobre 21, 2020
    As part of its foreign policy, Germany hopes to promote energy transitions abroad through international partnerships. A study by the IASS Potsdam analyses these bilateral energy partnerships. Building on its reputation as an energy transition frontrunner, Germany is currently pursuing a soft power strategy aimed at winning over foreign countries to its policy approaches in […]
  • Study finds go-to hormone for cycad propagation ineffective octobre 21, 2020
    Newly published thesis research by a University of Guam master's graduate reveals that propagation of cycads through stem cuttings does not benefit from a commonly used rooting hormone.
  • Scientists develop algorithm to help relieve pressure on the NHS octobre 21, 2020
    New research suggests an algorithm could be used to help optimise the sharing of healthcare resources during the Covid-19 pandemic, preventing NHS intensive care units (ICU) from becoming overwhelmed.
  • Collaborative care to meet mental health demands in era of COVID-19 octobre 21, 2020
    The need for collaborative care among health care professionals to meet mental health demands in the COVID-19 pandemic is discussed in this Viewpoint.